Private biotech company focused on developing modulators of intracellular protein-protein interactions employing a proprietary technology platform. The most advanced of these first-in-class therapeutics, an oral modulator of dysregulated transcription, is currently in preclinical development.

Location

Schärenmoosstrasse 77, 8052 Zürich, Switzerland

Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2013
  • Number of employees in Switzerland
    1-9
Key business